A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.

作者： M Lloyd Jones , S Hummel , N Bansback , B Orr , M Seymour

关键词: Raltitrexed 、 Oncology 、 Irinotecan/Oxaliplatin 、 Camptothecin 、 Quality of life 、 Advanced colorectal cancer 、 Clinical effectiveness 、 Medicine 、 Cost effectiveness 、 Survival analysis 、 Internal medicine